Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,898 | 31,836 | 144,583 | 13,414 | 75,180 |
| Marketable Securities | 319,074 | 300,535 | 27,796 | 37,724 | 55,986 |
| Receivables | 39,879 | 64,652 | 41,874 | 1,960 | N/A |
| Inventories | 24,968 | 39,032 | 10,108 | 5,340 | N/A |
| TOTAL | $479,064 | $447,248 | $228,063 | $62,143 | $134,751 |
| Non-Current Assets | |||||
| PPE Net | 19,618 | 14,677 | 5,981 | 5,076 | 3,049 |
| Other Non-Current Assets | 14,100 | 254 | 263 | 263 | 45 |
| TOTAL | $33,718 | $14,931 | $6,244 | $5,339 | $3,094 |
| Total Assets | $512,782 | $462,179 | $234,307 | $67,482 | $137,845 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,758 | 16,863 | 18,769 | 6,814 | 3,300 |
| Accrued Expenses | 49,862 | 37,867 | 35,780 | 21,621 | 10,059 |
| TOTAL | $96,705 | $92,019 | $103,171 | $38,733 | $19,735 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 50,000 | N/A |
| Deferred Revenues | N/A | N/A | 2,763 | 1,099 | N/A |
| Other Non-Current Liabilities | 12,242 | 0 | 0 | 0 | 0 |
| TOTAL | $12,242 | $N/A | $N/A | $50,000 | $N/A |
| Total Liabilities | $108,947 | $92,019 | $103,171 | $88,733 | $19,735 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 90,374 | 78,182 | 64,648 | 53,575 | 36,232 |
| Common Shares | 903 | 782 | 646 | 394 | 361 |
| Retained earnings | -1,165,470 | -960,721 | -783,455 | -585,971 | -412,828 |
| Other shareholders' equity | 85 | -87 | -10 | -17 | -40 |
| TOTAL | $403,835 | $370,160 | $131,136 | $-21,251 | $118,110 |
| Total Liabilities And Equity | $512,782 | $462,179 | $234,307 | $67,482 | $137,845 |